98%
921
2 minutes
20
Background: The detection of indeterminate pulmonary nodules (IPN) at diagnosis of colorectal cancer (CRC) has increased. However, there is limited information on predictive factors for its progression (pPF) to pulmonary metastases (PM). This study aims to identify these pPF to select appropriate management strategies.
Methods: Single-center observational retrospective study including patients who underwent elective surgery for first non-metastatic CRC episode (January 2016- June 2019) with IPN at diagnosis. Patients were divided into those who developed PM in the same location as previous IPN (LM group) and those who did not (FM group).
Results: One hundred twenty-one patients were included; 4.9% developed PM in the same location as previous IPN. Univariate analysis revealed a significant difference in IPN size between groups with 8 (5, 10) mm in LM versus 3 (1, 5) mm in FM (P=0.006). ROC curve showed a size of ≥5 mm as the best cutoff point to predict IPN progression. Multivariate analysis identified size ≥5mm as the only independent pPF (OR 11.9, 95%CI 1.3-105.8, P=0.026). The median time to diagnose PM in LM group was 13.8(SD 5.2) months.
Conclusions: We recommend a closer follow-up for patients with CRC and IPN ≥5 mm at diagnosis so they will have a higher risk of developing PM.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.23736/S2724-5691.25.10760-0 | DOI Listing |
JAMA Cardiol
August 2025
Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Importance: Clonal hematopoiesis of indeterminate potential (CHIP) is the age-related clonal expansion of hematopoietic stem cells with leukemia-associated mutations. Certain CHIP mutations promote atherosclerosis and heart failure through immune-related pathways.
Objective: To test whether CHIP is associated with the development of myocarditis and pericarditis.
Eur Heart J
August 2025
Department of Medicine, Queen's University, Biosciences Complex Room 1520, 116 Barrie Street, Kingston, Ontario, Canada K7L 3N6.
Background And Aims: Multiple germline gene variants promote familial and idiopathic pulmonary arterial hypertension (PAH); however, none are consistently identified in associated PAH with connective tissue disease (APAH-CTD). Moreover, the role of somatic variants in genes mediating clonal haematopoiesis of indeterminate potential (CHIP) in PAH is unknown. Here, somatic and germline DNMT3A variants and CHIP gene variants in PAH were evaluated.
View Article and Find Full Text PDFPediatr Pulmonol
August 2025
Division of Endocrinology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Background: Cystic fibrosis-related diabetes (CFRD) can be associated with decline in pulmonary function and nutritional status. Earlier diagnosis of CFRD than offered by annual recommended oral glucose tolerance test (OGTT) and earlier initiation of insulin may help prevent clinical decline. This retrospective study investigates the utility of continuous glucose monitoring (CGM) for detection of hyperglycemia in patients with cystic fibrosis (CF).
View Article and Find Full Text PDFJ Am Coll Cardiol
August 2025
Cardiovascular Disease Initiative and Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address: mhonigb
Background: Clonal hematopoiesis of indeterminate potential (CHIP) is an emerging aging-related risk factor for cardiovascular disease (CVD). However, previous studies suggest that CHIP's relevance to CVD may diminish with advancing age.
Objectives: This study aimed to test the association of CHIP and its key subtypes with incident CVD in an older population.
Int J Surg
August 2025
Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China.